Metabiomed to Participate in Asia's Largest "Bangkok International Aesthetic Plastic Surgery Conference"

Meta Biomed, a high-performance biomedical materials specialist led by CEO Oh Seok-song, announced on June 12 that the company will participate in "IMCAS Asia 2026," Asia's largest aesthetic medicine and plastic surgery academic conference, to be held in Bangkok, Thailand starting on June 19.

During the event, Meta Biomed will operate its own exhibition booth and showcase a range of new aesthetic products, including its flagship brand "Da:all PDO Thread," as well as lifting products and skin boosters.

The main product, "Da:all," is the first domestically produced PDO absorbable suture to obtain the European CE MDR certification, recognized for its global-level safety. It is designed to effectively anchor subcutaneous tissue during minimally invasive procedures and support the wound area over an extended period. The product lineup consists of five types and 336 models, enabling the company to meet a wide variety of clinical demands.

Along with the exhibition, Meta Biomed will also host an exclusive academic session titled "Da:all PDO Thread Open Session." Through this session, the company plans to present clinical data on its products to global medical professionals and international buyers, actively pursue business partnerships, and expand its global business network.

This academic session will feature Dr. Woo-ram Kim, a board-certified member of both the Korean Society of Plastic and Reconstructive Surgeons (KPRS) and the International Society of Plastic, Reconstructive and Aesthetic Surgeons (IPRAS), as a speaker. Based on his extensive clinical experience in anti-aging and thread lifting, Dr. Kim will share insights on anatomical face remodeling, discuss the clinical safety and biocompatibility of Da products, and provide practical techniques that can be applied in clinical settings.

The session will take place at 2:00 PM local time on June 21. Any medical professionals or industry stakeholders visiting the venue can attend without prior registration.

A Meta Biomed representative stated, "With growing global interest in K-beauty, participating in this prestigious international aesthetic medicine conference gives us the opportunity to directly introduce the competitiveness of our products to medical professionals worldwide. We aim to use this event to strengthen our academic credibility and translate it into tangible overseas business achievements in the aesthetic field."

Meanwhile, Meta Biomed, established in 1990, is a specialized medical device company focusing on biodegradable sutures and dental materials. Recently, leveraging its proprietary biopolymer technology, the company has continuously expanded its medical beauty product lineup, including PDO threads, skin boosters, and fillers. Meta Biomed currently supplies its products to 110 countries worldwide, accelerating its growth as a high-performance biomedical materials company with a robust global network.

This content was produced with the assistance of AI translation services.